VITAMIN D AND PARATHYROID HORMONE PREDICT INCIDENT MAJOR ADVERSE CARDIAC EVENTS IN PATIENTS STARTING HAEMODIALYSIS: A REAL-WORLD ANALYSIS

被引：0
|
作者：
Mcdowell, Garry [1 ,2 ]
Downey, Robert [3 ]
Buckley, Benjamin [4 ]
Austin, Philip [5 ]
Lip, Gregory [2 ,6 ]
Rao, Anirudh [2 ,3 ]
机构：
[1] Liverpool John Moores Univ, Pharm & Biomol Sci, Liverpool, Merseyside, England
[2] Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Liverpool, Merseyside, England
[3] Royal Liverpool Univ Hosp, Nephrol & Transplantat, Liverpool, Merseyside, England
[4] Liverpool John Moores Univ, Sch Sport & Exercise Sci, Liverpool, Merseyside, England
[5] TriNetX, London, England
[6] Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
4787
引用
收藏
页码：I66 / I67
页数：2
相关论文
共 50 条
  • [31] Calcium, Parathyroid Hormone, and Vitamin D: Major Determinants of Chronic Pain in Hemodialysis Patients
    Golan, Eliezer
    Haggiag, Isabelle
    Os, Pnina
    Bernheim, Jacques
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (08): : 1374 - 1380
  • [32] Risk Factors Associated With Major Adverse Cardiovascular Events and Malignancies in Patients With Rheumatoid Arthritis in a Real-World Setting in Japan
    Yamaoka, Kunihiro
    Sugiyama, Naonobu
    Hoshi, Masato
    Jo, Joo-Young
    Shin, Kichul
    Hirano, Toshitaka
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (12)
  • [33] VITAMIN D, PARATHYROID HORMONE, SERUM CALCIUM AND PHOSPHORUS IN PATIENTS WITH SCHIZOPHRENIA AND MAJOR DEPRESSION
    Jamilian, H.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [34] A real-world pharmacovigilance study of cardiac adverse events induced by sugammadex in the FDA adverse event reporting system
    Lin, Xiao-Na
    Zeng, You-Jie
    Cao, Si
    Jing, Xi-Bo
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [35] Real-world incidence and outcomes of immune-related adverse events in NSCLC patients
    Knox, A.
    Cloney, T.
    Janssen, H.
    Solomon, B.
    Alexander, M.
    John, T.
    ANNALS OF ONCOLOGY, 2023, 34 : S1684 - S1684
  • [36] Safety evaluation of ILaris: a real-world analysis of adverse events based on the FAERS database
    Yi, Xueliang
    Wu, Shujie
    He, He
    Li, Yingjie
    EXPERT OPINION ON DRUG SAFETY, 2025,
  • [37] A real-world disproportionality analysis of the FDA adverse event reporting system events for ibuprofen
    Du, Yikuan
    Guo, Zhuoming
    Xu, Bijun
    Yang, Yujia
    Hu, Mianda
    Hu, Yanghui
    Yang, Yurong
    Zhang, Mengting
    Wang, Zhenjie
    Guo, Xiaochun
    Huang, Yixing
    Zhu, Jinfeng
    Zhang, Weichui
    Yang, Chun
    EXPERT OPINION ON DRUG SAFETY, 2025, 24 (02) : 201 - 211
  • [38] The real-world analysis of adverse events with teduglutide: a pharmacovigilance study based on the FAERS database
    Wang, Xiaogan
    Chen, Hao
    Han, Shuangshuang
    Li, Lingbo
    Chen, Hongjin
    Yang, Bolin
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [39] Adverse events associated with inclisiran: a real-world disproportionality analysis based on the FAERS database
    Cai, Xuyang
    Peng, Shaopeng
    Mu, Shangzhen
    Lei, Song
    Li, Juan
    Tang, Xiaoxue
    Qiu, Feng
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [40] Sorafenib safety evaluation: Real-world analysis of adverse events from the FAERS database
    Ning, Lin
    Tian, Yuan
    Chen, Di
    Han, Jie
    Xie, Guanyue
    Sun, Jianguang
    HELIYON, 2024, 10 (18)
12345